28
Growth Score in past quarter
pts
Heat Score 28 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1764354
Tacere Therapeutics develops therapies to identify and treat diseases.
John Monahan: Co-Founder and DirectorPast Role: Somatix Therapy, VP of R&D
About the Company
Tacere Therapeutics, Inc. specializes in the development of novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). Combining expertise in RNA interference (RNAi), gene medicine, and novel biologicals, Tacere possesses proprietary skill in the identification and development of RNAi therapeutics.



